1,102
Views
16
CrossRef citations to date
0
Altmetric
Commentary

Teaching tolerance

New approaches to enzyme replacement therapy for Pompe disease

, , , , , , , & show all
Pages 1459-1464 | Received 29 Jun 2012, Accepted 07 Jul 2012, Published online: 01 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anne S De Groot. (2013) Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?. Expert Review of Clinical Immunology 9:12, pages 1155-1157.
Read now
Giancarlo Parenti & Generoso Andria. (2013) Pharmacotherapy of Pompe disease. Expert Opinion on Orphan Drugs 1:6, pages 457-471.
Read now

Articles from other publishers (14)

Leiling Liu, Jiahui Hu, Hao Lei, Huali Qin, Chunfang Wang, Yajun Gui & Danyan Xu. (2023) Regulatory T Cells in Pathological Cardiac Hypertrophy: Mechanisms and Therapeutic Potential. Cardiovascular Drugs and Therapy.
Crossref
Line Gutte Borgwardt, Ferdinando Ceravolo, Giulia Zardi, Andrea Ballabeni & Allan Meldgaard Lund. (2022) Relationship between MAN2B1 genotype/subcellular localization subgroups, antidrug antibody detection, and long‐term velmanase alfa treatment outcomes in patients with alpha‐mannosidosis . JIMD Reports 64:2, pages 187-198.
Crossref
Jia-Xin Wan, Gyutae Lim, Jinhyuk Lee, Xiao-Bao Sun, De-Ying Gao, Yue-Xiu Si, Xin-Lei Shi, Guo-Ying Qian, Qian Wang & Yong-Doo Park. (2019) Inhibitory effect of phloroglucinol on α-glucosidase: Kinetics and molecular dynamics simulation integration study. International Journal of Biological Macromolecules 124, pages 771-779.
Crossref
J. Hordeaux, L. Dubreil, C. Robveille, J. Deniaud, Q. Pascal, B. Dequéant, J. Pailloux, L. Lagalice, M. Ledevin, C. Babarit, P. Costiou, F. Jamme, M. Fusellier, Y. Mallem, C. Ciron, C. Huchet, C. Caillaud & M-A Colle. (2017) Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease. Acta Neuropathologica Communications 5:1.
Crossref
Han-Hyuk Lim, Haiqing Yi, Takashi K. Kishimoto, Fengqin Gao, Baodong Sun & Priya S. Kishnani. (2017) A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease. Molecular Genetics and Metabolism Reports 13, pages 18-22.
Crossref
Moanaro Biswas, Geoffrey L. Rogers, Alexandra Sherman, Barry J. Byrne, David M. Markusic, Haiyan Jiang & Roland W. Herzog. (2017) Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin. Thrombosis and Haemostasis 117:01, pages 33-43.
Crossref
Boris Gorovits, Adrienne Clements-Egan, Mary Birchler, Meina Liang, Heather Myler, Kun Peng, Shobha Purushothama, Manoj Rajadhyaksha, Laura Salazar-Fontana, Crystal Sung & Li Xue. (2016) Pre-existing Antibody: Biotherapeutic Modality-Based Review. The AAPS Journal 18:2, pages 311-320.
Crossref
Paul Harmatz. (2015) Enzyme Replacement Therapies and Immunogenicity in Lysosomal Storage Diseases: Is There a Pattern?. Clinical Therapeutics 37:9, pages 2130-2134.
Crossref
Leslie P. Cousens, Leonard Moise & Anne S. De Groot. 2015. Biobetters. Biobetters 63 77 .
Xuan Li, Zhi-Rong Lü, Dong Shen, Yi Zhan, Jun-Mo Yang, Yong-Doo Park, Hai-Meng Zhou, Qing Sheng & Jinhyuk Lee. (2014) The inhibitory role of Co2+ on α-glucosidase: Inhibition kinetics and molecular dynamics simulation integration study. Process Biochemistry 49:11, pages 1913-1919.
Crossref
Sushrusha Nayak, Phillip A. Doerfler, Stacy L. Porvasnik, Denise D. Cloutier, Richie Khanna, Ken J. Valenzano, Roland W. Herzog & Barry J. Byrne. (2014) Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent. PLoS ONE 9:6, pages e98336.
Crossref
Daniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, Robert J Davidson, George Buchlis, Mustafa Yazicioglu, Gary C Pien, Jonathan D Finn, Virginia Haurigot, Alex Tai, David W Scott, Leslie P Cousens, Shangzhen Zhou, Anne S De Groot & Federico Mingozzi. (2013) Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Molecular Therapy 21:9, pages 1727-1737.
Crossref
Yan Su, Robert Rossi, Anne S De Groot & David W Scott. (2013) Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se. Journal of Leukocyte Biology 94:2, pages 377-383.
Crossref
Leslie P. Cousens, Yan Su, Elizabeth McClaine, Xin Li, Frances Terry, Robert Smith, Jinhee Lee, William Martin, David W. Scott & Anne S. De Groot. (2013) Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes. Journal of Diabetes Research 2013, pages 1-17.
Crossref